All Stories

  1. 2026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes
  2. Enhancing Asthma Management in Emergency Departments: New Approaches Are Vital for Effective Care
  3. Refractory Chylothorax in Primary Mediastinal Large B‐Cell Lymphoma: A Case of Superior Vena Cava Obstruction Thrombosis‐Induced Lymphatic Leak Salvaged by Mechanical Thrombectomy
  4. Is the SUNRISE study a new dawn in steroid stewardship?
  5. Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
  6. A 3-year prospective study to assess clinical characteristics and risk factors for exacerbations in patients with asthma-COPD overlap based on the GINA guideline compared with patients with asthma and COPD.
  7. Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —...
  8. Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis
  9. Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
  10. Validation of diagnosis codes for pleural diseases and procedure codes for relevant respiratory procedures in a healthcare database in Hong Kong: a single tertiary centre study
  11. Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
  12. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  13. Climate Change and Respiratory Care With Inhalers
  14. Prevalence and correlates of breathlessness in adults: an umbrella review and updated systematic review with meta-analysis in general and clinical populations
  15. Establishing the China–UK Cancer Prevention and Control Alliance
  16. Regenerative restoration of chronic obstructive pulmonary disease by human umbilical cord blood small extracellular vesicles
  17. Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
  18. COPD and Lung Cancer: Shared Risks and Connections
  19. Ground-Glass Opacities on Computed Tomography of the Thorax to Predict Progression of Emphysema: Are We There Yet?
  20. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  21. “Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients”. Kiki Waeijen-Smit, Mieke Crutsen, Spencer Keene, Marc Miravitlles, Ernesto Crisafulli, Antoni Torres, Christian...
  22. Green energy and sustainability
  23. Exhaled biomarkers for respiratory diseases
  24. Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong
  25. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
  26. ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)
  27. Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life
  28. Clinical characteristics of patients with COPD in Hong Kong
  29. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
  30. Retrospective comparison of the clinical outcomes between low and standard starting doses of intrapleural tissue plasminogen activator in pleural infection
  31. To determine the efficacy of autologous blood patch therapy in reducing air leak in secondary spontaneous pneumothorax.
  32. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
  33. Can we predict asthma exacerbations?
  34. Risk of air and surface contamination during application of different noninvasive respiratory support for patients with COVID-19
  35. Minimize systemic oral corticosteroids use and reduce harm for patients with asthma
  36. 1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control
  37. Global initiative for asthma: 30 years of promoting evidence‐based asthma care
  38. GOLD 2023 executive summary: comments from Asia's perspective
  39. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
  40. Smoking: Quit to win
  41. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma [Corrigendum]
  42. Hospital Burden of Chronic Obstructive Pulmonary Disease in Hong Kong – The Trend from 2006 to 2014
  43. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
  44. Phenotyping empyema by pleural fluid culture results and macroscopic appearance: an 8-year retrospective study
  45. Severe asthma, more than that?
  46. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma
  47. Advancement of asthma management in the past decade
  48. Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
  49. Aspergillus sensitization as a treatable trait in COPD
  50. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
  51. Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?
  52. Leading women in respiratory medicine: The role of the APSR in promoting gender equity and inclusiveness
  53. Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates
  54. Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
  55. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
  56. Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial
  57. Virus neutralization of SARS-CoV-2 Omicron variant BA.2 in those vaccinated with three doses of BNT162b2 or CoronaVac vaccines.
  58. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
  59. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  60. Global Initiative for Asthma Strategy 2021
  61. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes
  62. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  63. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
  64. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  65. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
  66. Prologue to leading women in respiratory medicine series
  67. A territory‐wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong
  68. Reply
  69. Predictive value of blood eosinophil count in COPD
  70. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial
  71. Evaluation of bronchial challenge test results for use in assessment of paediatric eczema: a retrospective series
  72. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  73. ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
  74. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  75. Characterisation of patients hospitalised for asthma exacerbations in Hong Kong
  76. “High-Risk” Clinical and Inflammatory Clusters in COPD of Chinese Descent
  77. Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD : A randomized controlled trial
  78. Time course of blood oxygen saturation responding to short-term fine particulate matter among elderly healthy subjects and patients with chronic obstructive pulmonary disease
  79. Real-Time Monitoring of the Effects of Personal Temperature Exposure on the Blood Oxygen Saturation Level in Elderly People with and without Chronic Obstructive Pulmonary Disease: A Panel Study in Hong Kong
  80. Fungal Sensitization and Its Association with Frequent Exacerbations in COPD
  81. Inflammatory Phenotypes in Chronic Obstructive Pulmonary Disease (COPD) of Chinese Descent
  82. Obstructive Sleep Apnea and CPAP Treatment Response in Patients with Non Alcoholic Fatty Liver Disease
  83. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
  84. Asthma–COPD overlap: No formal definition and simple diagnostic tool so far?
  85. Twenty‐five years of Respirology : Advances in COPD
  86. Comprehensive care for chronic obstructive pulmonary disease
  87. Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
  88. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease
  89. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations
  90. GINA 2019: a fundamental change in asthma management
  91. Prevalence and burden of asthma in China: time to act
  92. Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission
  93. Author Correction: A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  94. Use of Berlin questionnaire in comparison to polysomnography and home sleep study in patients with obstructive sleep apnea
  95. The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness
  96. Exhaled air dispersion from high flow nasal cannula (HFNC) vs CPAP
  97. COMBINATION OF NON CPAP THERAPY IN PATIENTS WITH OSA
  98. Short-course pulmonary rehabilitation and exacerbations and activity of COPD patients over 1 year
  99. Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control
  100. Identification of chronic obstructive pulmonary disease subgroups in 13 Asian cities
  101. Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis
  102. CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers
  103. Year in review 2017: Chronic obstructive pulmonary disease and asthma
  104. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control
  105. Adherence to a COPD treatment guideline among patients in Hong Kong
  106. Many patients labelled as having mild asthma do not have well-controlled asthma
  107. Drug Treatment for Early-Stage COPD
  108. Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS
  109. The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma
  110. A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  111. Year in review 2016: Chronic obstructive pulmonary disease and asthma
  112. Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea
  113. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections
  114. Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial
  115. Acute exacerbation of COPD
  116. Year in review 2015: Asthma and chronic obstructive pulmonary disease
  117. Genetic effects of multiple asthma loci identified by genomewide association studies on asthma and spirometric indices
  118. Mesenteric fat thickness is associated with metabolic syndrome independently of Apnoea-Hypopnoea Index in subjects with obstructive sleep apnoea
  119. A Randomized Controlled Study to Examine the Effect of a Lifestyle Modification Program in OSA
  120. Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress
  121. Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
  122. Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population
  123. A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea
  124. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer
  125. Suicidal ideation in Chinese patients with chronic obstructive pulmonary disease: a controlled study
  126. Exhaled Air Dispersion During Noninvasive Ventilation via Helmets and a Total Facemask
  127. Prevalence of Obstructive Sleep Apnea Syndrome and CPAP Adherence in the Elderly Chinese Population
  128. Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology
  129. COPD care programme can reduce readmissions and in-patient bed days
  130. Quality of Life in Older Patients With Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  131. Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology
  132. Early dislodgement of Indwelling Pleural Catheter ( IPC ): a balancing act
  133. Differences in asthma genetics between Chinese and other populations
  134. Insomnia in Older Adults with Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  135. Mesenteric fat thickness is associated with increased risk of obstructive sleep apnoea
  136. Depressive disorders in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a controlled study
  137. Recent advances in asthma biomarker research
  138. Year in review 2012: Asthma and chronic obstructive pulmonary disease
  139. An Adjunct Intervention for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
  140. Diagnosis of silicotuberculosis by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)
  141. Changing Prevalence of Allergic Diseases in the Asia-Pacific Region
  142. Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population
  143. Asthma and bronchodilator responsiveness are associated with polymorphic markers of ARG1, CRHR2 and chromosome 17q21
  144. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese
  145. Air pollution and chronic obstructive pulmonary disease
  146. Year in review 2011: Asthma, chronic obstructive pulmonary disease and airway biology
  147. The Role of Circulating Serotonin in the Development of Chronic Obstructive Pulmonary Disease
  148. Evaluation of the asthma control test: A reliable determinant of disease stability and a predictor of future exacerbations
  149. A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in Obstructive sleep apnea syndrome
  150. Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia
  151. Erratum to: Atopy in Children with Eczema
  152. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD
  153. Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia
  154. A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD
  155. Gene-gene Interactions for Asthma and Bronchodilator Responsiveness in Chinese Adults
  156. The lower the body weight for COPD patients, the more effective is pulmonary rehabilitation?
  157. Effect of Acu-TENS on Post-exercise Expiratory Lung Volume in Subjects with Asthma – a randomized controlled trial
  158. Effects of Air Pollution on Lung Health
  159. PRS11 COST ANALYSIS OF DIFFERENT PHARMACOTHERAPIES IN SUBJECTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE PUBLIC SECTOR OF HONG KONG
  160. Prevalence of Sleep-Disordered Breathing in Chinese Elderly
  161. Can continuous pump feeding reduce the incidence of pneumonia in nasogastric tube-fed patients? A randomized controlled trial
  162. Effect of 4 weeks of Acu-TENS on functional capacity and β-endorphin level in subjects with chronic obstructive pulmonary disease: A randomized controlled trial
  163. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status
  164. Atopy in children with eczema
  165. Validation of Embletta portable diagnostic system for identifying patients with suspected obstructive sleep apnoea syndrome (OSAS)
  166. CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
  167. Effect of Acu-TENS on post-exercise expiratory lung volume in subjects with asthma—A randomized controlled trial
  168. Asthma Control Test correlates well with the treatment decisions made by asthma specialists
  169. Predicting changes in clinical status of young asthmatics: Clinical scores or objective parameters?
  170. Outdoor air pollution: impact on chronic obstructive pulmonary disease patients
  171. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis
  172. Activation of Peripheral Th17 Lymphocytes in Patients with Asthma
  173. Identifying Uncontrolled Asthma in Young Children: Clinical Scores or Objective Variables?
  174. Expression and Functional Analysis of Toll-Like Receptors of Peripheral Blood Cells in Asthmatic Patients: Implication for Immunopathological Mechanism in Asthma
  175. Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease
  176. Patterns of food and aeroallergen sensitization in childhood eczema
  177. Prevalence and risk factors of airflow obstruction in an elderly Chinese population
  178. Geographic differences in clinical characteristics and management of COPD: the EPOCA study
  179. Validation of a portable recording device (ApneaLink) for identifying patients with suspected obstructive sleep apnoea syndrome
  180. The burden of lung disease in Hong Kong: A report from the Hong Kong Thoracic Society
  181. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
  182. Sonographic Measurement of Lateral Parapharyngeal Wall Thickness in Patients with Obstructive Sleep Apnea
  183. Viral Etiology of Acute Exacerbations of COPD in Hong Kong
  184. Effects of air pollution on asthma hospitalization rates in different age groups in Hong Kong
  185. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong
  186. Reference values of diffusing capacity of non-smoking Chinese in Hong Kong
  187. Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma
  188. Eczema exacerbation and food atopy beyond infancy: How should we advise Chinese parents about dietary history, eczema severity, and skin prick testing?
  189. Decreased T-bet expression and changes in chemokine levels in adults with asthma
  190. A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD
  191. Are exhaled breath condensates useful in monitoring asthma?
  192. Polymorphisms in the IL-4, IL-4 Receptor α Chain, TNF-α, and Lymphotoxin-α Genes and Risk of Asthma in Hong Kong Chinese Adults
  193. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness
  194. Sleep-disordered breathing and continuous positive airway pressure compliance in a group of commercial bus drivers in Hong Kong
  195. 12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong
  196. Response by J.C.W. Mak, H.C.M. Leung, S.P. Ho, F.W.S. Ko, A.H.K. Cheung, M.S.M. Ip and M.M.W. Chan‐Yeung
  197. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease
  198. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients
  199. Aberrant Expression of CC and CXC Chemokines and Their Receptors in Patients with Asthma
  200. Increasing COPD awareness
  201. Updated Spirometric Reference Values for Adult Chinese in Hong Kong and Implications on Clinical Utilization
  202. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
  203. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong
  204. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community-based study in Hong Kong and Guangzhou
  205. Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis
  206. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children
  207. The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors
  208. DETERMINING THE LOWER LIMITS OF NORMAL OF SPIROMETRIC REFERENCE VALUES FOR ADULT CHINESE IN HONG KONG
  209. THE LONG-TERM IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) ON PULMONARY FUNCTION, EXERCISE CAPACITY, AND QUALITY OF LIFE IN A COHORT OF SURVIVORS
  210. High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren
  211. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma
  212. A Comparison of Airway and Serum Matrix Metalloproteinase-9 Activity Among Normal Subjects, Asthmatic Patients, and Patients With Asthmatic Mucus Hypersecretion
  213. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
  214. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong
  215. Analysis of Growth Factors and Inflammatory Cytokines in Exhaled Breath Condensate from Asthmatic Children
  216. Declining asthma prevalence in Hong Kong Chinese schoolchildren
  217. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey
  218. Early results of endoscopic lung volume reduction for emphysema
  219. The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome
  220. Akute Exazerbation der COPD
  221. Increased macrophage‐derived chemokine in exhaled breath condensate and plasma from children with asthma
  222. Analysis of Th2-specific chemokines in exhaled breath condensate from asthmatic children*1
  223. Cephalometric assessment of craniofacial morphology in Chinese patients with obstructive sleep apnoea
  224. Apoptosis and B-Cell Lymphoma-2 of Peripheral Blood T Lymphocytes and Soluble Fas in Patients with Allergic Asthma
  225. Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance
  226. Prevalence of wheeze, bronchial hyper-responsiveness and asthma in the elderly Chinese
  227. Prevalence of snoring and sleep-disordered breathing in a group of commercial bus drivers in Hong Kong
  228. Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction
  229. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ , IL-4, IL-10 and IL-13) in patients with allergic asthma
  230. Determinants of Continuous Positive Airway Pressure Compliance in a Group of Chinese Patients With Obstructive Sleep Apnea
  231. Temporal relationship between air pollution and hospital admissions for asthmatic children in Hong Kong
  232. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis
  233. Effects of Augmented Continuous Positive Airway Pressure Education and Support on Compliance and Outcome in a Chinese Population
  234. Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells
  235. Evaluation of the efficacy of a hospital‐based asthma education programme in patients of low socioeconomic status in Hong Kong